Ventrus Biosciences Stock Price (NASDAQ:ASMB)

Add to My Stocks
$36.55 $0.17 (0.46%) ASMB stock closing price Aug 17, 2018 (Closing)
Prev Close* : $36.72
Market Cap:
Day Low: $35.7
52 Week Low: $24.17
Open: $36.6
Volume: -
Day High: $36.89
52 Week High: $67.36

Latest Stock Market News

Latest Articles

Ventrus Biosciences News - From Partners

ASMB Stockcharts

View ASMB PE ratio, PS ratio stocks charts and compare with peers.
ASMB Chart
Note: Compare Ventrus Biosciences stock price history with the index and industry peers.

Ventrus Biosciences Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Ventrus Biosciences Returns

(return on equity)

Ventrus Biosciences Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ASMB Industry Peers

Company Price Change (%)
Celator Pharma (CPXX)30.240 (0%)
Bactolac Pharma (BTCA)1200000 (0%)
Cytodyn (CYDY)0.550.04 (7.84%)
Paratek Pharma (PRTK)10.20.2 (2%)
Chimerix (CMRX)4.050.1 (2.41%)
Anacor Pharma (ANAC)99.20 (0%)
Newlink Genetics (NLNK)2.720.03 (1.09%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Supernus Pharma (SUPN)44.81.3 (2.99%)
Corium (CORI)8.930.24 (2.76%)
Mallinckrodt (MNK)34.690.55 (1.61%)
Dr. Reddy's Laboratories (RDY)33.830.52 (1.56%)
BAUSCH HEALTH (BHC)21.890.2 (0.92%)
Mylan (MYL)38.150.3 (0.79%)
Allergan (AGN)185.61.39 (0.75%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)22.430.41 (1.8%)
Progenics Pharma (PGNX)7.810.08 (1.01%)
Akorn (AKRX)18.990.16 (0.84%)
Teligent (TLGT)4.260.01 (0.23%)
Top losers from Medical-Generic Drugs industry
* As of Aug 18, 2018

Assembly Biosciences Inc Stock News - Partner Headlines

Ventrus Biosciences Financial Statements

income statement20172016201520142013
Net Sales or Revenues9.01M----
Net Income-42.8M-44.26M-28.45M-23.78M-19.4M
Total Operating Expense61.24M45.27M29.64M23.94M19.59M
View Ventrus Biosciences income statement
balance sheet20172016201520142013
Total Assets169.3M98.11M133.74M71.22M27.13M
Total Liabilities56.18M18.24M15M12.65M2.63M
Shareholders Equity113.11M79.87M118.74M58.57M24.49M
View Ventrus Biosciences balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities44.36M3.75M1.78M-2.51M-0.11M
Net Cash from (used by) Operating Activities1.86M-34.88M-18.69M-14.97M-17.79M
Increase (Decrease) in Prop Plant And Equipment-0.86M-0.14M-0.05M-0.14M-0.01M
View Ventrus Biosciences cash flow statement

Ventrus Biosciences Stock Message Board

Ventrus Biosciences stock price ended the last trading day at $36.55. Looking at Ventrus Biosciences market capitalization, which currently stands at $930.05M, we can say that ASMB stock is a Small Cap stock. A value investor must look at the fundamentals of a stock, and perform Ventrus Biosciences valuation, even though in the short-term, sentiment and current breaking news might affect Ventrus Biosciences stock price.

For recognizing and analyzing the real performance of Ventrus Biosciences stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 223,211 on the last trading day, as is evident from Ventrus Biosciences stock chart, and ASMB stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Ventrus Biosciences dividend per share was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of ASMB, view Ventrus Biosciences stock price history.